Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$399K Sell
753
-102
-12% -$47.1K ﹤0.01% 1136
2026
Q1
$411K Sell
855
-34
-4% -$17.4K 0.01% 1053
2025
Q4
$506K Sell
889
-498
-36% -$283K 0.01% 918
2025
Q3
$713K Sell
1,387
-54
-4% -$23.6K 0.01% 754
2025
Q2
$452K Buy
+1,441
New +$433K 0.01% 944
2025
Q1
Sell
-1,249
Closed -$416K 1550
2024
Q4
$416K Sell
1,249
-394
-24% -$134K 0.01% 997
2024
Q3
$548K Sell
1,643
-158
-9% -$60K 0.01% 856
2024
Q2
$733K Buy
+1,801
New +$713K 0.01% 642

Other funds holding MEDP

Choreo LLC's MEDP Position: Q2 2026 in Review

Choreo LLC reduced its Medpace (MEDP) stake by 12% in Q2 2026, selling an estimated $47.1K and leaving 753 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Choreo LLC first reported a position in MEDP in Q2 2024 and has held it in 8 quarters since. The position peaked at $733K in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Choreo LLC held 753 shares of Medpace worth $399K as of Q2 2026.
  • Choreo LLC sold 102 Medpace shares in Q2 2026, an estimated $47.1K.
  • Medpace made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1136 holding.
  • Choreo LLC first reported a position in Medpace in Q2 2024 and has held it in 8 quarters since.
  • Choreo LLC's Medpace position peaked at $733K in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.